Polaryx Therapeutics To Participate In The 25th Annual Needham Virtual Healthcare Conference
Globe Newswire (Wed, 1-Apr 8:30 AM ET)
Globe Newswire (Tue, 17-Mar 8:30 AM ET)
Polaryx Therapeutics Strengthens Ties with Krabbe Community Ahead of SOTERIA Trial Initiation
Market Chameleon (Thu, 12-Mar 4:37 AM ET)
Globe Newswire (Thu, 12-Mar 8:30 AM ET)
Globe Newswire (Fri, 27-Feb 8:30 AM ET)
Market Chameleon (Tue, 17-Feb 3:42 AM ET)
Polaryx Therapeutics Selects Contract Research Organization for SOTERIA Phase 2 Basket Trial
Globe Newswire (Tue, 17-Feb 8:30 AM ET)
Polaryx’s PLX-200 Shows Promising Results in Krabbe Disease: SOTERIA Trial Set to Launch in 2026
Market Chameleon (Tue, 10-Feb 3:47 AM ET)
Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium
Globe Newswire (Tue, 10-Feb 8:30 AM ET)
Polaryx Therapeutics Welcomes New Members of the Board of Directors
Globe Newswire (Thu, 5-Feb 8:30 AM ET)
Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small-molecule drug candidates designed to address core pathological mechanisms common to LSDs. The Company has one reportable segment: lysosomal storage disorders. The lysosomal storage disorders segment consists of the Company's costs associated with the preclinical and clinical development of the Company's product candidates.
Polaryx Therapeutics trades on the NASDAQ stock market under the symbol PLYX.
As of April 2, 2026, PLYX stock price declined to $7.14 with 247,443 million shares trading.
PLYX has a market cap of $338.03 million. This is considered a Small Cap stock.
PLYX support price is $6.31 and resistance is $8.89 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PLYX shares will trade within this expected range on the day.
